James H. Crona

2.3k total citations
15 papers, 1.2k citations indexed

About

James H. Crona is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, James H. Crona has authored 15 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Surgery and 4 papers in Oncology. Recurrent topics in James H. Crona's work include Ion channel regulation and function (4 papers), Receptor Mechanisms and Signaling (4 papers) and Nicotinic Acetylcholine Receptors Study (4 papers). James H. Crona is often cited by papers focused on Ion channel regulation and function (4 papers), Receptor Mechanisms and Signaling (4 papers) and Nicotinic Acetylcholine Receptors Study (4 papers). James H. Crona collaborates with scholars based in United States, United Kingdom and Bulgaria. James H. Crona's co-authors include Edwin C. Johnson, Laura E. Chavez-Noriega, Kathryn Elliott, Arturo Urrutia, Mark Washburn, Tony Priestley, Harry R. Davis, S. Altmann, Xiaorui Yao and Michael P. Graziano and has published in prestigious journals such as Journal of Biological Chemistry, Neuroscience and Antimicrobial Agents and Chemotherapy.

In The Last Decade

James H. Crona

15 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James H. Crona United States 13 912 432 227 158 155 15 1.2k
M. Tastenoy Belgium 20 831 0.9× 679 1.6× 185 0.8× 87 0.6× 88 0.6× 38 1.1k
Amador Haro Spain 15 379 0.4× 458 1.1× 243 1.1× 66 0.4× 144 0.9× 37 1.2k
Toshiya Kanaji Japan 8 565 0.6× 281 0.7× 76 0.3× 45 0.3× 129 0.8× 10 1.0k
Lisa M. DiPilato United States 10 956 1.0× 331 0.8× 107 0.5× 28 0.2× 236 1.5× 11 1.2k
Craig A. Doupnik United States 21 1.5k 1.6× 753 1.7× 45 0.2× 63 0.4× 143 0.9× 32 1.8k
Masao Tsuda Japan 16 660 0.7× 683 1.6× 195 0.9× 51 0.3× 116 0.7× 27 1.1k
C. Mark Eppler United States 15 942 1.0× 814 1.9× 93 0.4× 54 0.3× 261 1.7× 25 1.3k
N. Boujrad United States 14 622 0.7× 425 1.0× 110 0.5× 134 0.8× 132 0.9× 19 1.1k
Wesley Lebel United States 8 627 0.7× 672 1.6× 73 0.3× 35 0.2× 299 1.9× 12 992
H. Paris France 17 535 0.6× 241 0.6× 107 0.5× 76 0.5× 143 0.9× 39 827

Countries citing papers authored by James H. Crona

Since Specialization
Citations

This map shows the geographic impact of James H. Crona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James H. Crona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James H. Crona more than expected).

Fields of papers citing papers by James H. Crona

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James H. Crona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James H. Crona. The network helps show where James H. Crona may publish in the future.

Co-authorship network of co-authors of James H. Crona

This figure shows the co-authorship network connecting the top 25 collaborators of James H. Crona. A scholar is included among the top collaborators of James H. Crona based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James H. Crona. James H. Crona is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Gamse, Joshua T., et al.. (2020). Decreased immune response in monkeys administered a human T-effector cell agonist (OX40) antibody. Toxicology and Applied Pharmacology. 409. 115285–115285. 4 indexed citations
2.
Price, Karen, Anthony M. Fletcher, Lila Ramaiah, et al.. (2018). Abstract LB-B33: Nonclinical safety evaluation of two distinct second generation variants of anti-CTLA4 monoclonal antibody, ipilimumab, in monkeys. Molecular Cancer Therapeutics. 17(1_Supplement). LB–B33. 10 indexed citations
3.
Gu, Zhengxian, Jason D. Graci, Frederick Lahser, et al.. (2013). Identification of PTC725, an Orally Bioavailable Small Molecule That Selectively Targets the Hepatitis C Virus NS4B Protein. Antimicrobial Agents and Chemotherapy. 57(7). 3250–3261. 15 indexed citations
4.
Engler, Harald, Xiaoping Zhou, Lilly Mark, et al.. (2007). Small interfering RNA-mediated selective knockdown of NaV1.8 tetrodotoxin-resistant sodium channel reverses mechanical allodynia in neuropathic rats. Neuroscience. 146(2). 812–821. 101 indexed citations
5.
Yang, Shu‐Wei, Tze‐Ming Chan, Alexei V. Buevich, et al.. (2007). Novel steroidal saponins, Sch 725737 and Sch 725739, from a marine starfish, Novodinia antillensis. Bioorganic & Medicinal Chemistry Letters. 17(20). 5543–5547. 12 indexed citations
6.
Hawes, Brian E., Xiaorui Yao, James H. Crona, et al.. (2006). In Vivo Responsiveness to Ezetimibe Correlates with Niemann-Pick C1 Like-1 (NPC1L1) Binding Affinity: Comparison of Multiple Species NPC1L1 Orthologs. Molecular Pharmacology. 71(1). 19–29. 54 indexed citations
7.
Iyer, Sai Prasad N., Xiaorui Yao, James H. Crona, et al.. (2005). Characterization of the putative native and recombinant rat sterol transporter Niemann-Pick C1 Like 1 (NPC1L1) protein. Biochimica et Biophysica Acta (BBA) - General Subjects. 1722(3). 282–292. 71 indexed citations
8.
Zhou, Xiaoping, Xiaowei Dong, James H. Crona, Maureen G. Maguire, & Tony Priestley. (2003). Vinpocetine Is a Potent Blocker of Rat NaV1.8 Tetrodotoxin-Resistant Sodium Channels. Journal of Pharmacology and Experimental Therapeutics. 306(2). 498–504. 55 indexed citations
9.
Altmann, S., Harry R. Davis, Xiaorui Yao, et al.. (2002). The identification of intestinal scavenger receptor class B, type I (SR-BI) by expression cloning and its role in cholesterol absorption. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1580(1). 77–93. 124 indexed citations
10.
Shan, Li-Xin, Xudong Qiao, James H. Crona, et al.. (2000). Identification of a Novel Neuromedin U Receptor Subtype Expressed in the Central Nervous System. Journal of Biological Chemistry. 275(50). 39482–39486. 92 indexed citations
11.
Chavez-Noriega, Laura E., Alison Gillespie, Kenneth A. Stauderman, et al.. (2000). Characterization of the recombinant human neuronal nicotinic acetylcholine receptors α3β2 and α4β2 stably expressed in HEK293 cells. Neuropharmacology. 39(13). 2543–2560. 63 indexed citations
12.
Stauderman, Kenneth A., M. Akong, Gönül Veliçelebi, et al.. (1998). Characterization of Human Recombinant Neuronal Nicotinic Acetylcholine Receptor Subunit Combinations α2β4, α3β4 and α4β4 Stably Expressed in HEK293 Cells. Journal of Pharmacology and Experimental Therapeutics. 284(2). 777–789. 47 indexed citations
13.
Chavez-Noriega, Laura E., James H. Crona, Mark Washburn, et al.. (1997). Pharmacological Characterization of Recombinant Human Neuronal Nicotinic Acetylcholine Receptors hα2β2, hα2β4, hα3β2, hα3β4, hα4β2, hα4β4 and hα7 Expressed in Xenopus Oocytes. Journal of Pharmacology and Experimental Therapeutics. 280(1). 346–356. 180 indexed citations
14.
Chavez-Noriega, Laura E., James H. Crona, Mark Washburn, et al.. (1997). Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors h alpha 2 beta 2, h alpha 2 beta 4, h alpha 3 beta 2, h alpha 3 beta 4, h alpha 4 beta 2, h alpha 4 beta 4 and h alpha 7 expressed in Xenopus oocytes.. PubMed. 280(1). 346–56. 344 indexed citations
15.
Hess, Stephen D., Lorrie P. Daggett, James H. Crona, et al.. (1996). Cloning and functional characterization of human heteromeric N-methyl-D-aspartate receptors.. Journal of Pharmacology and Experimental Therapeutics. 278(2). 808–816. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Tastenoy Breakdown of academic impact, for papers by Amador Haro Breakdown of academic impact, for papers by Toshiya Kanaji Breakdown of academic impact, for papers by Lisa M. DiPilato Breakdown of academic impact, for papers by Craig A. Doupnik Breakdown of academic impact, for papers by Masao Tsuda Breakdown of academic impact, for papers by C. Mark Eppler Breakdown of academic impact, for papers by N. Boujrad Breakdown of academic impact, for papers by Wesley Lebel Breakdown of academic impact, for papers by H. Paris
Rankless by CCL
2026